Israeli Gov’t Unveil mRNA Jabs That Turn Human Cells Into “Black Death Incubators”

The Israeli government has unveiled chilling mRNA jabs engineered by military scientists at the Israel Institute for Biological Research (IIBR), which incorporate virulence genes from a mutant Yersinia pestis—the bacterium behind the Black Death—potentially turning human cells into deadly plague incubators. This biowarfare-tinged “vaccine” research, funded amid a global push for engineered pandemics, has ignited worldwide outrage over its ethical horrors and risks of unleashing catastrophic outbreaks.

Governments worldwide are bankrolling such criminal endeavors without restraint, enabling scientists to craft the next plandemic under the guise of innovation. The IIBR’s project, blending plague genes with mRNA technology, exemplifies this madness, raising profound concerns about vaccine safety, bioethics, and the weaponization of biology, as no one steps in to halt this perilous path toward self-inflicted doom.

Naturalnews.com reports: The genetically altered strain, known as F1? Kimberley53, was developed by deleting the caf1 gene from a fully virulent plague variant, thereby removing the bacterium’s immune-shielding capsule. This modified strain was designed to simulate a “vaccine escape” pathogen—one that could potentially circumvent immune defenses. Researchers then extracted genetic segments from this engineered plague and inserted them into a dual-component mRNA vaccine.

This vaccine contains synthetic mRNA instructions for producing two modified plague proteins:

1. LcrV – a virulence protein used by Y. pestis to suppress immune responses and infect human cells.
2. F1 – a protein that normally forms a capsule around the bacterium to shield it from immune detection.

Both proteins were further fused with a human antibody domain (Fc region) to enhance stability and immune response. The mRNA was chemically altered with N1-methyl-pseudouridine (m1?), a synthetic nucleotide also used in COVID-19 vaccines. While m1? increases mRNA longevity and protein output, studies have linked it to immune evasion, autoimmune responses, and even accelerated tumor growth.

Critics argue that this research, carried out under the banner of pandemic preparedness and biodefense, treads dangerously close to violating international bioweapons laws. Israel, notably, is not a signatory of the Biological Weapons Convention, and the IIBR has long been associated with military-grade biological research. Despite this, the study was peer-reviewed and supported by the European Research Council and the EU’s Horizon 2020 program.

Legal and ethical experts warn that the Israeli team’s approach—engineering a mutant version of the plague and using its virulence mechanisms to program human cells—raises profound biosecurity and ethical concerns. These include the potential misuse of the technology, the risks of accidental release, and the health dangers posed by synthetic mRNA vaccines that direct human cells to produce harmful bacterial proteins.

The use of m1? in this platform is especially concerning, as multiple studies have highlighted its role in creating “rogue” proteins through genetic frameshifts and in promoting cancer metastasis. Critics argue that this adds another layer of risk, especially as booster doses accumulate in individuals.

This project marks a troubling intersection of biotechnology, military interests, and global health policy. It also sets a precedent for normalizing the use of genetically engineered Tier 1 pathogens—those classified as top-level bioterrorism threats—in vaccine development. While intended as a defensive measure, the manipulation of plague genes for insertion into human cells via mRNA platforms underscores the growing threat of dual-use research, where the line between medical innovation and biowarfare becomes increasingly blurred.